5
views
0
recommends
+1 Recommend
1 collections
    0
    shares

      Call for Papers: Beyond Biology: The Crucial Role of Sex and Gender in Oncology

      Submit here before May 31, 2024

      About Oncology Research and Treatment: 2.4 Impact Factor I 3.3 CiteScore I 0.495 Scimago Journal & Country Rank (SJR)

      • Record: found
      • Abstract: found
      • Article: found

      Effect of Combined Natural Human β–lnterferon and Radiation on Human Tumor Cells

      research-article

      Read this article at

      ScienceOpenPublisher
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Background: This investigation is done to evaluate the extent of β-Interferon-induced radiosensitization and the underlying mechanisms by which β-Interferon alters the radiation response of two different human tumours in vitro. Material and Methods: Two human tumors were studied in vitro. One was the second passage of a human squamous cell carcinoma of the head and neck (ZMK-1), the other was the breast cancer cell line MCF-7. Cells were cultured by standard methods. β-Interferon was used in concentrations from 10 to 1,000 IE/ml medium, incubation times were 3 h (pulse) or for the remainder of the incubation for colony formation (continuous). Cells were either attached to their flasks or in suspension. The cells were irradiated with 200-kV X-rays at dose levels from 2 to 10 Gy. Evaluation was done by colony assay. Results: For MCF-7 cells we found an antiproliferative effect caused by β-Interferon depending on concentrations and incubation times. When combined with X-radiation we found no additional effects of β-Interferon for both kinds of cells irradiated in suspension. When the cells were irradiated attached to their flasks, β-Interferon caused a slight radiosensibilization with respect to the MCF-7 cells and a pronounced effect with respect to the ZMK-1 cells, the isoeffect enhancement ratio being 1.5, determined at the 10% survival level. Conclusion: These results demonstrate that under the influence of β-Interferon repair of sublethal radiation damage of MCF-7 and ZMK-1 cells is decreased by a short preirradiation incubation time. Additionally, lethal radiation of ZMK-1 cells is increased by β-Interferon.

          Related collections

          Author and article information

          Journal
          ONK
          Oncol Res Treat
          10.1159/issn.2296-5270
          Oncology Research and Treatment
          S. Karger AG
          2296-5270
          2296-5262
          1996
          1996
          12 May 2009
          : 19
          : 6
          : 501-504
          Affiliations
          aKlinik und Poliklinik für Strahlentherapie und Radioonkologie der Ludwig-Maximilians-Universität München, Klinikum Großhadern, München bKlinik und Poliklinik für Strahlentherapie der Georg-August Universität Göttingen
          Article
          218863 Onkologie 1996;19:501–504
          10.1159/000218863
          0909a1d4-6361-41ec-a916-3b8824b27035
          © 1996 S. Karger AG, Basel

          Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher. Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug. Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

          History
          Page count
          Pages: 4
          Categories
          Original Article

          Oncology & Radiotherapy,Pathology,Surgery,Obstetrics & Gynecology,Pharmacology & Pharmaceutical medicine,Hematology
          Cell culture,&beta:-Interferon,Radiosensitization

          Comments

          Comment on this article